Merck · 20 hours ago
Scientist III - (iPSC-Derived Gut Models)
Merck is a leading company in the pharmaceutical industry, and they are seeking a Scientist III to develop and optimize advanced human in vitro gut model systems for preclinical research. This role involves working collaboratively to generate data that supports therapeutic discovery and understanding disease biology.
Responsibilities
Develop, optimize, and execute iPSC-derived gut model systems, including 3D intestinal organoids, epithelial monolayers, and microphysiological platforms
Perform iPSC maintenance and differentiation into intestinal epithelial and endodermal lineages
Establish and run co-culture systems with immune cells (e.g., macrophages, dendritic cells, T cells) to model inflammatory disease contexts
Design and execute mono- and combination-therapy studies, including dose–response and time-course experiments using biologics and small molecules
Apply quantitative functional readouts such as barrier integrity (TEER, permeability), wound healing, mucus layer assays, and cytokine profiling
Conduct inflammatory and cell-state analyses using ELISA/MSD, qPCR/RT-qPCR, flow cytometry, and imaging-based techniques
Collaborate with data science partners on transcriptomic profiling (bulk and/or single-cell) and quantitative data analysis
Implement genetic and pharmacologic perturbations to interrogate mechanisms and predict combination responsiveness
Assess assay reproducibility, dynamic range, and throughput; adapt workflows to plate-based and automated formats
Present experimental plans, results, and project updates to internal stakeholders and senior leadership while maintaining rigorous documentation and SOPs
Ensure compliance with laboratory safety standards and proper maintenance of cell lines, reagents, and equipment
Qualification
Required
Master's degree with 5+ years of relevant experience or PhD with 1–2+ years of relevant experience
Field of study: Molecular Biology, Cellular Biology, Immunology, Pharmacology, or related discipline
Hands-on experience with human cell culture and at least one of the following: iPSC maintenance and differentiation into epithelial/endodermal lineages, Intestinal organoids (enteroids) or epithelial monolayers, Proven ability to design, execute, and troubleshoot functional assays, including dose–response studies, Strong data analysis, documentation, and scientific presentation skills, Demonstrated success working in collaborative, cross-functional research environments, Excellent verbal and written communication skills
Preferred
Direct experience with iPSC-derived intestinal models (3D organoids, 2D monolayers, Transwells, gut-on-chip systems)
Expertise in barrier function assays, imaging-based analyses, and cytokine profiling
Experience with automation, liquid handling, and high-throughput assay development
Background in inflammatory disease biology
Prior industry experience in preclinical pharmacology or combination therapy testing
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase